Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TP-102 in Diabetic Foot Ulcers
NCT04803708Phase 2Completed
- Sponsor
- TechnoPhage
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of TP-102 in diabetic foot ulcer (DFU), bacterial wound infection, sponsored by TechnoPhage. Started Mar 2021; status: completed.
02
Drugs
TP-102
03
Conditions
diabetic foot ulcer (DFU)bacterial wound infection
Beyond the preview
Go deeper on NCT04803708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04803708.